Physician profile
Drefus E Thompson
NPI 1336418490
$3,582.20
in general payments reported to CMS, 2019-2025
35 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $163 · 2023: $803 · 2024: $2,252 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,751 · Food and Beverage: $1,469 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,750.62 |
| Food and Beverage | $1,468.98 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,909.34 | 2024 | Enseal |
| Intuitive Surgical, INC. | $200.00 | 2023 | Davinci Xi |
| Ethicon US, LLC | $186.55 | 2023-2024 | Echelon; Endopath, Harmonic, Megadyne |
| Baxter Healthcare | $150.82 | 2023-2024 | Perclot, Floseal |
| Novo Nordisk INC | $96.70 | 2023-2024 | Wegovy |
| Antares Pharma, INC. | $72.36 | 2025 | Xyosted |
| Bluewind Medical | $62.18 | 2025 | Revi |
| Abbvie INC. | $60.03 | 2023-2025 | |
| Grifols USA, LLC | $59.29 | 2022-2023 | Gamunex-C |
| Sk Life Science, INC. | $57.61 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.40 | 2023 | Gammagard |
| Medtronic, INC. | $49.44 | 2024 | Interstim |
| Endo USA, INC. | $45.85 | 2025 | Xiaflex |
| Lilly USA, LLC | $45.34 | 2023-2024 | Zepbound, Jardiance |
| Tolmar, INC. | $44.57 | 2025 | Eligard, Jatenzo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $43.43 | 2023 | |
| Merz Pharmaceuticals, LLC | $42.05 | 2023 | Xeomin |
| Procept Biorobotics Corporation | $40.99 | 2025 | |
| Genzyme Corporation | $33.33 | 2023 | |
| Jazz Pharmaceuticals INC. | $26.90 | 2022 | |
| Corcept Therapeutics | $25.05 | 2025 | Korlym |
| Amgen INC. | $24.40 | 2022 | |
| Csl Behring | $23.29 | 2023 | Hizentra |
| Silk Road Medical, INC. | $22.73 | 2022 | |
| Biogen, INC. | $22.32 | 2023 | Avonex, Vumerity, Plegridy |
| Alexion Pharmaceuticals, INC. | $22.30 | 2022 | |
| Ucb, INC. | $21.23 | 2023 | |
| Acella Pharmaceuticals, LLC | $20.59 | 2025 | NP Thyroid 60 |
| Kci USA, INC. | $19.99 | 2023 | V.A.C. Veraflo, V.A.C.Ulta |
| Kerecis Limited | $18.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $16.78 | 2024 | Flexitouch Plus, Entre Plus |
| Amneal Pharmaceuticals LLC | $15.50 | 2022 | |
| Avion Pharmaceuticals | $15.26 | 2022 | |
| Argenx US, INC. | $15.25 | 2023 | Vyvgart |
| Cequr Corporation | $14.54 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drefus Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.